FOXP3 vector (V009983)

Basic Vector Information

Vector Name:
FOXP3
Antibiotic Resistance:
Ampicillin
Length:
9841 bp
Type:
Expression vector
Replication origin:
ori
Source/Author:
Masiuk KE, Laborada J, Grazia Roncarolo M, Hollis RP, Kohn DB.

FOXP3 vector Vector Map

FOXP39841 bp4008001200160020002400280032003600400044004800520056006000640068007200760080008400880092009600AmpR promoterAmpRoriCAP binding sitelac promoterlac operatorM13 revT3 promoterCMV enhancerCMV promoter5' LTR (truncated)HIV-1 PsiRREgp41 peptideProtein TatcPPT/CTSCNS1CNS2CNS3FOXP35'UTRForkhead box protein P33'UTRU3 region LTR (first half)A2 insulatorU3 region LTR (second half)5' LTR (truncated)SV40 poly(A) signalSV40 oriT7 promoterM13 fwdf1 ori

FOXP3 vector Sequence

Copy Sequence

Download GeneBank File(.gb)

LOCUS       V009983                 9841 bp    DNA     circular SYN 17-DEC-2018
DEFINITION  Exported.
ACCESSION   V009983
VERSION     V009983
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 9841)
  AUTHORS   Masiuk KE, Laborada J, Grazia Roncarolo M, Hollis RP, Kohn DB.
  TITLE     Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 9841)
  AUTHORS   Masiuk KE, Laborada J, Grazia Roncarolo M, Hollis RP, Kohn DB.
  TITLE     Direct Submission
  JOURNAL   Submitted (02-OCT-2018) Microbiology, Immunology and Molecular
            Genetics, University of California, Los Angeles, 610 Charles E.
            Young Dr. East, Los Angeles, CA 90095, USA
REFERENCE   3  (bases 1 to 9841)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 9841)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     ##Assembly-Data-START##
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
            SGRef: number: 1; type: "Journal Article"; journalName:
            "Unpublished"
            SGRef: number: 2; type: "Journal Article"; journalName: "Submitted
            (02-OCT-2018) Microbiology, Immunology and Molecular Genetics,
            University of California, Los Angeles, 610 Charles E. Young Dr.
            East, Los Angeles, CA 90095, USA"
            SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..9841
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     promoter        27..131
                     /label="AmpR promoter"
     CDS             132..989
                     /label="AmpR"
                     /note="beta-lactamase"
     rep_origin      1163..1751
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     protein_bind    2039..2060
                     /label="CAP binding site"
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     promoter        2075..2105
                     /label="lac promoter"
                     /note="promoter for the E. coli lac operon"
     protein_bind    2113..2129
                     /label="lac operator"
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be
                     relieved by adding lactose or
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     primer_bind     2137..2153
                     /label="M13 rev"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     promoter        2174..2192
                     /label="T3 promoter"
                     /note="promoter for bacteriophage T3 RNA polymerase"
     enhancer        2293..2672
                     /label="CMV enhancer"
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        2673..2876
                     /label="CMV promoter"
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     LTR             2891..3071
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     misc_feature    2891..2986
                     /label="R region LTR"
                     /note="R region LTR"
     misc_feature    2897..3071
                     /label="U5 region LTR"
                     /note="U5 region LTR"
     misc_feature    3118..3243
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     misc_feature    3736..3969
                     /label="RRE"
                     /note="The Rev response element (RRE) of HIV-1 allows for
                     Rev-dependent mRNA export from the nucleus to the
                     cytoplasm."
     CDS             4152..4196
                     /label="gp41 peptide"
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
                     al., 2013)"
     CDS             4345..4386
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
                     /label="Protein Tat"
     misc_feature    4489..4606
                     /label="cPPT/CTS"
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     regulatory      4655..4892
                     /label="CNS1"
                     /note="CNS1"
                     /regulatory_class="enhancer"
     regulatory      4893..5252
                     /label="CNS2"
                     /note="CNS2"
                     /regulatory_class="enhancer"
     regulatory      5252..5470
                     /label="CNS3"
                     /note="CNS3"
                     /regulatory_class="enhancer"
     regulatory      5471..5853
                     /label="FOXP3"
                     /note="FOXP3"
                     /regulatory_class="promoter"
     5'UTR           5854..6041
     CDS             6042..7334
                     /gene="FOXP3"
                     /label="Forkhead box protein P3"
                     /note="Forkhead box protein P3 from Homo sapiens.
                     Accession#: Q9BZS1"
     3'UTR           7338..8213
     misc_feature    8291..8331
                     /label="U3 region LTR (first half)"
                     /note="U3 region LTR (first half)"
     misc_feature    8332..8597
                     /label="A2 insulator"
                     /note="A2 insulator"
     misc_feature    8598..8614
                     /label="U3 region LTR (second half)"
                     /note="U3 region LTR (second half)"
     LTR             8615..8795
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     polyA_signal    8867..9000
                     /label="SV40 poly(A) signal"
                     /note="SV40 polyadenylation signal"
     rep_origin      9027..9162
                     /label="SV40 ori"
                     /note="SV40 origin of replication"
     promoter        complement(9195..9213)
                     /label="T7 promoter"
                     /note="promoter for bacteriophage T7 RNA polymerase"
     primer_bind     complement(9223..9239)
                     /label="M13 fwd"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     rep_origin      9384..9839
                     /direction=RIGHT
                     /label="f1 ori"
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"

This page is informational only.